Waystar Holding Corp. 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring on October 1, 2025. Waystar Holding Corp. (Nasdaq: WAY), an emerging growth company, announced the completion of its previously announced acquisition of Iodine Software Holdings, Inc. ("Iodine").
Key Financial Metrics and Capital Structure Changes
The filing details significant changes to the Company's capital structure to fund the Iodine acquisition:
- Acquisition Consideration: Total consideration was approximately $458.6 million, comprised of:
- Cash: Approximately $458,598,269.88.
- Equity: 16,639,906 shares of Waystar Common Stock issued to Iodine equityholders (valued at $37.31 per share per the Merger Agreement).
- Debt Financing (Amendment No. 12):
- Incremental Term Loans: Incurred $250.0 million to fund a portion of the acquisition.
- Revolving Credit Facility: Capacity increased from $400.0 million to $500.0 million.
- Interest Rates: Reduced to Adjusted Term SOFR + 1.50% (down from 1.75%) and Alternate Base Rate + 0.50% (down from 0.75%), subject to leverage ratio adjustments.
Note: This filing does not provide updated revenue, profit, cash flow, or margin figures for the reporting period.
Material Changes Versus Prior Period
The primary material change is the expansion of the Company's debt capacity and the issuance of unregistered equity securities:
- Debt: Addition of $250 million in term loans and a $100 million increase in revolving credit capacity.
- Equity: Issuance of ~16.6 million shares of common stock under Section 4(a)(2) and Rule 506(b) exemptions.
- Corporate Governance: Board of Directors expanded from 12 to 13 members with the appointment of Lauren Young (Class II Director).
Outlook, Risks, and Management Commentary
Management Commentary: The Company completed the Mergers via a sequence involving Morton Merger Sub 1, Inc. and Isotope Holding, LLC. The transaction was funded through a combination of cash and stock, supported by the new credit facility amendment.
Risks and Contingencies:
- Debt Covenants: The new interest rates are variable and depend on the achievement of specific leverage ratios.
- Unregistered Securities: The stock issuance relied on representations that recipients were "accredited investors."
- Integration: As with any acquisition, risks related to the integration of Iodine's operations and technology exist, though specific integration risks are not detailed in this 8-K.
Key Facts for Investor Verification
- Verify the total pro-forma debt load and leverage ratios post-acquisition to assess covenant compliance.
- Confirm the dilution impact of the 16,639,906 newly issued shares on existing shareholders.
- Review the full text of Amendment No. 12 (Exhibit 10.1) for specific leverage ratio thresholds triggering interest rate adjustments.
- Monitor future filings for the first financial results including Iodine's revenue and EBITDA contribution.